{"schema_version":"secwatch.filing_event.v1","accession":"0001606498-23-000050","form_type":"8-K","ticker":"AVNS","cik":"0001606498","company_name":"AVANOS MEDICAL, INC.","filed_at":"2023-06-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:39.639631+00:00","generated_at":"2026-06-14T04:58:40.646976+00:00","sec_items":["1.01","7.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Avanos sells Respiratory Health to SunMed for $110M, accelerates portfolio focus","bullets":["Definitive agreement to sell substantially all RH assets for $110M cash; close expected late 2023.","Transaction includes BALLARD, MICROCUFF, endOclear brands and two manufacturing facilities in Mexico.","Avanos will provide transition services; net proceeds enhance balance sheet for M&A in core categories.","Divestiture is key component of three-year transformation to focus on Digestive Health and Pain Management."],"urls":{"canonical":"https://secwatch.observer/filing/0001606498-23-000050","json":"https://secwatch.observer/filing/0001606498-23-000050.json","markdown":"https://secwatch.observer/filing/0001606498-23-000050.md","text":"https://secwatch.observer/filing/0001606498-23-000050.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1606498/000160649823000050/0001606498-23-000050-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1606498/000160649823000050/avns-20230607.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T04:58:40.646976+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"350815d1cf3706846e7f45c26ed2acc37ac6d24d","claim":"AVANOS MEDICAL, INC. entered into Purchase Agreement with SunMed Group Holdings, LLC valued at $110 million (effective 2023-06-07).","evidence_excerpt":"On June 7, 2023, Avanos Medical, Inc. (the “Company”), entered into a Purchase Agreement (the “Purchase Agreement”) by and among the Company and certain of its affiliates and SunMed Group Holdings, LLC (“Buyer”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1606498/000160649823000050/0001606498-23-000050-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"asset purchase"},{"label":"Counterparty","value":"SunMed Group Holdings, LLC"},{"label":"Value","value":"$110 million"},{"label":"Effective","value":"2023-06-07"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}